Literature DB >> 27129237

Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.

Michael C DeSantis1, Jin H Kim1, Hanna Song1, Per Johan Klasse2, Wei Cheng3.   

Abstract

The envelope glycoprotein (Env) gp120/gp41 is required for HIV-1 infection of host cells. Although in general it has been perceived that more Env gives rise to higher infectivity, the precise quantitative dependence of HIV-1 virion infectivity on Env density has remained unknown. Here we have developed a method to examine this dependence. This method involves 1) production of a set of single-cycle HIV-1 virions with varied density of Env on their surface, 2) site-specific labeling of Env-specific antibody Fab with a fluorophore at high efficiency, and 3) optical trapping virometry to measure the number of gp120 molecules on individual HIV-1 virions. The resulting gp120 density per virion is then correlated with the infectivity of the virions measured in cell culture. In the presence of DEAE-dextran, the polycation known to enhance HIV-1 infectivity in cell culture, virion infectivity follows gp120 density as a sigmoidal dependence and reaches an apparent plateau. This quantitative dependence can be described by a Hill equation, with a Hill coefficient of 2.4 ± 0.6. In contrast, in the absence of DEAE-dextran, virion infectivity increases monotonically with gp120 density and no saturation is observed under the experimental conditions. These results provide the first quantitative evidence that Env trimers cooperate on the virion surface to mediate productive infection by HIV-1. Moreover, as a result of the low number of Env trimers on individual virions, the number of additional Env trimers per virion that is required for the optimal infectivity will depend on the inclusion of facilitating agents during infection.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  glycoprotein; human immunodeficiency virus (HIV); infection; optical tweezers; protein cross-linking; single particle analysis; single-molecule biophysics

Mesh:

Substances:

Year:  2016        PMID: 27129237      PMCID: PMC4933225          DOI: 10.1074/jbc.M116.729210

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Authors:  I Mondor; S Ugolini; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Single-molecule detection using continuous wave excitation of two-photon fluorescence.

Authors:  Ximiao Hou; Wei Cheng
Journal:  Opt Lett       Date:  2011-08-15       Impact factor: 3.776

4.  A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.

Authors:  Dan H Barouch; Zhi-yong Yang; Wing-pui Kong; Birgit Korioth-Schmitz; Shawn M Sumida; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Ayako Miura; John R Mascola; Norman L Letvin; Gary J Nabel
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

6.  Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1.

Authors:  P J Klasse; J P Moore
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.

Authors:  Jakub Chojnacki; Thorsten Staudt; Bärbel Glass; Pit Bingen; Johann Engelhardt; Maria Anders; Jale Schneider; Barbara Müller; Stefan W Hell; Hans-Georg Kräusslich
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

8.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

9.  Point centromeres contain more than a single centromere-specific Cse4 (CENP-A) nucleosome.

Authors:  Josh Lawrimore; Kerry S Bloom; E D Salmon
Journal:  J Cell Biol       Date:  2011-11-14       Impact factor: 10.539

10.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more
  15 in total

1.  Dense Array of Spikes on HIV-1 Virion Particles.

Authors:  Armando Stano; Daniel P Leaman; Arthur S Kim; Lei Zhang; Ludovic Autin; Jidnyasa Ingale; Syna K Gift; Jared Truong; Richard T Wyatt; Arthur J Olson; Michael B Zwick
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 2.  The Density Code for the Development of a Vaccine?

Authors:  Wei Cheng
Journal:  J Pharm Sci       Date:  2016-09-17       Impact factor: 3.534

3.  Optical manipulation of a single human virus for study of viral-cell interactions.

Authors:  Ximiao Hou; Michael C DeSantis; Chunjuan Tian; Wei Cheng
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-09-16

4.  eCD4-Ig Variants That More Potently Neutralize HIV-1.

Authors:  Ina Fetzer; Matthew R Gardner; Meredith E Davis-Gardner; Neha R Prasad; Barnett Alfant; Jesse A Weber; Michael Farzan
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

5.  Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5.

Authors:  Isabelle Staropoli; Jérémy Dufloo; Olivier Schwartz; Nicoletta Casartelli; Anaïs Ducher; Pierre-Henri Commere; Anna Sartori-Rupp; Sophie Novault; Timothée Bruel; Valérie Lorin; Hugo Mouquet
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

6.  A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.

Authors:  Ina Fetzer; Meredith E Davis-Gardner; Matthew R Gardner; Barnett Alfant; Jesse A Weber; Neha R Prasad; Amber S Zhou; Michael Farzan
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

7.  Microfluidic-based high-throughput optical trapping of nanoparticles.

Authors:  Abhay Kotnala; Yi Zheng; Jianping Fu; Wei Cheng
Journal:  Lab Chip       Date:  2017-06-13       Impact factor: 6.799

8.  Synthetic Liposomal Mimics of Biological Viruses for the Study of Immune Responses to Infection and Vaccination.

Authors:  Wei-Yun Wholey; James L Mueller; Corey Tan; Jeremy F Brooks; Julie Zikherman; Wei Cheng
Journal:  Bioconjug Chem       Date:  2020-01-23       Impact factor: 4.774

9.  HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell Activation.

Authors:  Jing Deng; Yu-Ya Mitsuki; Guomiao Shen; Jocelyn C Ray; Claudia Cicala; James Arthos; Michael L Dustin; Catarina E Hioe
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.

Authors:  Stefania Dispinseri; Massimiliano Secchi; Maria Franca Pirillo; Monica Tolazzi; Martina Borghi; Cristina Brigatti; Maria Laura De Angelis; Marco Baratella; Elena Bazzigaluppi; Giulietta Venturi; Francesca Sironi; Andrea Canitano; Ilaria Marzinotto; Cristina Tresoldi; Fabio Ciceri; Lorenzo Piemonti; Donatella Negri; Andrea Cara; Vito Lampasona; Gabriella Scarlatti
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.